This report by Dr. Francesca Maltecca, PhD, and Erica Spirito, Postdoctoral Researcher, summarizes their work aimed at identifying potential therapeutic molecules to address calcium dysregulation in ARSACS. Their research is part of a two-year project funded by the Ataxia Charlevoix–Saguenay Foundation. Read more here.
“Targeting Cav2.1 to recover firing defects and degeneration of Purkinje neurons in ARSACS”
